Detalhe da pesquisa
1.
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis.
J Neuroinflammation;
21(1): 91, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38609999
2.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry;
95(5): 410-418, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37940409
3.
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
J Clin Immunol;
41(2): 315-323, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33236261
4.
Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
J Med Virol;
93(4): 2243-2251, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33165922
5.
Risk and outcomes of COVID-19 in patients with multiple sclerosis.
Eur J Neurol;
28(11): 3712-3721, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34152073
6.
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
Eur J Clin Microbiol Infect Dis;
40(4): 761-769, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33083917
7.
Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis.
Mult Scler Relat Disord;
86: 105595, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38598952
8.
Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis.
Front Public Health;
12: 1397845, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38711771
9.
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
CNS Drugs;
38(3): 231-238, 2024 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38418770
10.
Emerging biomarkers for improving pregnancy planning in multiple sclerosis.
Front Neurol;
15: 1292296, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38426179
11.
Predictive models of multiple sclerosis-related cognitive performance using routine clinical practice predictors.
Mult Scler Relat Disord;
76: 104849, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37356257
12.
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
Front Immunol;
14: 1288169, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37954589
13.
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
Vaccines (Basel);
11(4)2023 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37112698
14.
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine.
Vaccines (Basel);
11(9)2023 Aug 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37766078
15.
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
JAMA Neurol;
80(4): 397-403, 2023 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36848127
16.
The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosis.
Mult Scler Relat Disord;
64: 103959, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35717900
17.
B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab.
Mult Scler Relat Disord;
68: 104218, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36270253
18.
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis.
Mult Scler Relat Disord;
59: 103669, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35150979
19.
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Front Immunol;
13: 842354, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35386690
20.
Low serum neurofilament light chain values identify optimal responders to dimethyl fumarate in multiple sclerosis treatment.
Sci Rep;
11(1): 9299, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33927255